## VALENTINA HOYOS

| | Title| Assistant Professor  
---|---  
Institution| Baylor College of Medicine  
Department| Department of Medicine  
Address| 1102 BATES  
Houston, TX 77030  
  
Email|
![](https://profiles.viictr.org/profile/modules/CustomViewPersonGeneralInfo/EmailHandler.ashx?msg=Vqo85GvTKYX0CKfi%2bXTRCraPKl%2bPkzA%3d&rnd=47cf7dab-d3a6-44d4-930d-0b73ecd9a065)  
vCard| [Download
vCard](https://profiles.viictr.org/profile/modules/CustomViewPersonGeneralInfo/vcard.aspx?subject=23479202)  
  

Other Positions| Title| Assistant Professor  
---|---  
Institution| Baylor College of Medicine  
Department| Breast Center  
Division| Breast Cancer Center  
  
  
Title| Assistant Professor  
Institution| Baylor College of Medicine  
Department| Center for Cell & Gene Therapy  
Division| Center for Cell & Gene Therapy  
  
  
Title| Assistant Professor  
Institution| Baylor College of Medicine  
Department| Duncan Cancer Center  
Division| Cancer Center  
  
  
  
  
![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
Bibliographic  

![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
selected publications

Publications listed below are automatically derived from MEDLINE/PubMed and
other sources, which might result in incorrect or missing publications.
Faculty can
[login](https://profiles.viictr.org/loginOptions.aspx?pin=send&method=login&edit=true)
to make corrections and additions.

Newest | Oldest | Most Cited | Most Discussed | Timeline | Field Summary | Plain Text

PMC Citations indicate the number of times the publication was cited by
articles in PubMed Central, and the Altmetric score represents citations in
news articles and social media. (Note that publications are often cited in
additional ways that are not shown here.) Fields are based on how the National
Library of Medicine (NLM) classifies the publication's journal and might not
represent the specific topic of the publication. Translation tags are based on
the publication type and the MeSH terms NLM assigns to the publication. Some
publications (especially newer ones and publications not in PubMed) might not
yet be assigned Field or Translation tags.) Click a Field or Translation tag
to filter the publications.

  1. Savage SR, Yi X, [Lei JT](https://profiles.viictr.org/profile/6998694), Wen B, Zhao H, Liao Y, Jaehnig EJ, [Somes LK](https://profiles.viictr.org/profile/28999354), [Shafer PW](https://profiles.viictr.org/profile/24845191), [Lee TD](https://profiles.viictr.org/profile/37471990), Fu Z, Dou Y, Shi Z, Gao D, **Hoyos V** , Gao Q, Zhang B. Pan-cancer proteogenomics expands the landscape of therapeutic targets. Cell. 2024 Jun 17. PMID: [38917788](//www.ncbi.nlm.nih.gov/pubmed/38917788).

Citations:  Fields:

Cel Cell Biology

  2. Leung WK, Torres Chavez AG, French-Kim M, [Shafer P](https://profiles.viictr.org/profile/24845191), Mamonkin M, Hill LC, Kuvalekar M, Velazquez Y, Watanabe A, Watanabe N, Hoyos V, Lulla PD, [Leen AM](https://profiles.viictr.org/profile/268626), Leung WK, Torres Chavez AG, French-Kim M, Shafer P, [Mamonkin M](https://profiles.viictr.org/profile/1826306), Hill LC, Kuvalekar M, Velazquez Y, Watanabe A, [Watanabe N](https://profiles.viictr.org/profile/3009961), **Hoyos V** , [Lulla P](https://profiles.viictr.org/profile/3010220), Leen AM. Targeting IDH2R140Q and other neoantigens in acute myeloid leukemia. Blood. 2024 Apr 25; 143(17):1726-1737. PMID: [38241630](//www.ncbi.nlm.nih.gov/pubmed/38241630); PMCID: [PMC11103096](//www.ncbi.nlm.nih.gov/pmc/articles/PMC11103096).

Citations:  Fields:

Hem Hematology

  3. [Shafer P](https://profiles.viictr.org/profile/24845191), Leung WK, Woods M, Choi JM, Rodriguez-Plata CM, [Maknojia A](https://profiles.viictr.org/profile/31189463), Mosquera A, [Somes LK](https://profiles.viictr.org/profile/28999354), Joubert J, Manliguez A, Ranjan R, [Burt B](https://profiles.viictr.org/profile/8354542), Lee HS, Zhang B, [Fuqua S](https://profiles.viictr.org/profile/269832), [Rooney C](https://profiles.viictr.org/profile/268355), [Leen AM](https://profiles.viictr.org/profile/268626), **Hoyos V**. Incongruity between T cell receptor recognition of breast cancer hotspot mutations ESR1 Y537S and D538G following exogenous peptide loading versus endogenous antigen processing. Cytotherapy. 2024 03; 26(3):266-275. PMID: [38231165](//www.ncbi.nlm.nih.gov/pubmed/38231165); PMCID: [PMC10922969](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10922969).

Citations:  Fields:

Cel Cell BiologyThe Therapeutics

Translation:Humans

  4. Chamorro DF, [Somes LK](https://profiles.viictr.org/profile/28999354), **Hoyos V**. Engineered Adoptive T-Cell Therapies for Breast Cancer: Current Progress, Challenges, and Potential. Cancers (Basel). 2023 Dec 26; 16(1). PMID: [38201551](//www.ncbi.nlm.nih.gov/pubmed/38201551); PMCID: [PMC10778447](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10778447).

Citations:

  5. **Hoyos V** , [Vasileiou S](https://profiles.viictr.org/profile/22016531), Kuvalekar M, Watanabe A, Tzannou I, Velazquez Y, French-Kim M, Leung W, [Lulla S](https://profiles.viictr.org/profile/34811365), Robertson C, Foreman C, Wang T, Bulsara S, [Lapteva N](https://profiles.viictr.org/profile/269143), [Grilley B](https://profiles.viictr.org/profile/266987), Ellis M, Osborne CK, Coscio A, [Nangia J](https://profiles.viictr.org/profile/266130), [Heslop HE](https://profiles.viictr.org/profile/269811), [Rooney CM](https://profiles.viictr.org/profile/268355), Vera JF, [Lulla P](https://profiles.viictr.org/profile/3010220), [Rimawi M](https://profiles.viictr.org/profile/269416), [Leen AM](https://profiles.viictr.org/profile/268626). Multi-antigen-targeted T-cell therapy to treat patients with relapsed/refractory breast cancer. Ther Adv Med Oncol. 2022; 14:17588359221107113. PMID: [35860837](//www.ncbi.nlm.nih.gov/pubmed/35860837); PMCID: [PMC9290161](//www.ncbi.nlm.nih.gov/pmc/articles/PMC9290161).

Citations:

  6. [Shafer P](https://profiles.viictr.org/profile/24845191), Kelly LM, **Hoyos V**. Cancer Therapy With TCR-Engineered T Cells: Current Strategies, Challenges, and Prospects. Front Immunol. 2022; 13:835762. PMID: [35309357](//www.ncbi.nlm.nih.gov/pubmed/35309357); PMCID: [PMC8928448](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8928448).

Citations:  Fields:

All Allergy and Immunology

Translation:HumansCells

  7. Chen N, Higashiyama N, **Hoyos V**. Predictive Biomarkers of Immune Checkpoint Inhibitor Response in Breast Cancer: Looking beyond Tumoral PD-L1. Biomedicines. 2021 Dec 08; 9(12). PMID: [34944679](//www.ncbi.nlm.nih.gov/pubmed/34944679); PMCID: [PMC8698415](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8698415).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/34944679/citedby/)

  8. Nalawade SA, [Shafer P](https://profiles.viictr.org/profile/24845191), Bajgain P, [McKenna MK](https://profiles.viictr.org/profile/23496083), Ali A, Kelly L, Joubert J, [Gottschalk S](https://profiles.viictr.org/profile/270181), [Watanabe N](https://profiles.viictr.org/profile/3009961), [Leen A](https://profiles.viictr.org/profile/268626), [Parihar R](https://profiles.viictr.org/profile/3009684), Vera Valdes JF, **Hoyos V**. Selectively targeting myeloid-derived suppressor cells through TRAIL receptor 2 to enhance the efficacy of CAR T cell therapy for treatment of breast cancer. J Immunother Cancer. 2021 11; 9(11). PMID: [34815355](//www.ncbi.nlm.nih.gov/pubmed/34815355); PMCID: [PMC8611441](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8611441).

Citations:
[7](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/34815355/citedby/) Fields:

Neo NeoplasmsThe Therapeutics

Translation:HumansAnimalsCells

  9. McKenna MK, Englisch A, Brenner B, Smith T, **Hoyos V** , [Suzuki M](https://profiles.viictr.org/profile/265870), [Brenner MK](https://profiles.viictr.org/profile/268200). Mesenchymal stromal cell delivery of oncolytic immunotherapy improves CAR-T cell antitumor activity. Mol Ther. 2021 Dec 01; 29(12):3529-3533. PMID: [34706248](//www.ncbi.nlm.nih.gov/pubmed/34706248); PMCID: [PMC8636171](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8636171).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/34706248/citedby/) Fields:

Mol Molecular BiologyThe Therapeutics

  10. Mouabbi JA, Chand M, Asghar IA, Sakhi R, Ockner D, Dul CL, Hadid T, Aref A, [Rimawi MF](https://profiles.viictr.org/profile/269416), **Hoyos V**. Lumpectomy followed by radiation improves survival in HER2 positive and triple-negative breast cancer with high tumor-infiltrating lymphocytes compared to mastectomy alone. Cancer Med. 2021 07; 10(14):4790-4795. PMID: [34080777](//www.ncbi.nlm.nih.gov/pubmed/34080777); PMCID: [PMC8290225](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8290225).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/34080777/citedby/) Fields:

Neo Neoplasms

Translation:HumansCells

  11. Ferrari F, Salviato E, [Brenner MK](https://profiles.viictr.org/profile/268200), [Gottschalk S](https://profiles.viictr.org/profile/270181), **Hoyos V** , Arnone CM, Polito VA, Mastronuzzi A, Carai A, Diomedi FC, Antonucci L, Petrilli LL, Vinci M, Scarsella M, De Stefanis C, Weber G, Quintarelli C, De Angelis B, Locatelli F, Caruana I, Del Bufalo F. Oncolytic adenovirus and gene therapy with EphA2-BiTE for the treatment of pediatric high-grade gliomas. J Immunother Cancer. 2021 05; 9(5). PMID: [33963009](//www.ncbi.nlm.nih.gov/pubmed/33963009); PMCID: [PMC8108682](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8108682).

Citations:
[6](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/33963009/citedby/) Fields:

Neo NeoplasmsThe Therapeutics

Translation:HumansAnimalsCells

  12. [McKenna MK](https://profiles.viictr.org/profile/23496083), Englisch A, Brenner B, Smith T, **Hoyos V** , [Suzuki M](https://profiles.viictr.org/profile/265870), [Brenner MK](https://profiles.viictr.org/profile/268200). Mesenchymal stromal cell delivery of oncolytic immunotherapy improves CAR-T cell antitumor activity. Mol Ther. 2021 05 05; 29(5):1808-1820. PMID: [33571680](//www.ncbi.nlm.nih.gov/pubmed/33571680); PMCID: [PMC8116608](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8116608).

Citations:
[8](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/33571680/citedby/) Fields:

Mol Molecular BiologyThe Therapeutics

Translation:HumansAnimalsCells

  13. Higashiyama N, [Nangia J](https://profiles.viictr.org/profile/266130), Shafaee MN, Chen N, [Michael BL](https://profiles.viictr.org/profile/268573), [Rimawi M](https://profiles.viictr.org/profile/269416), **Hoyos V**. Dose-reduced trastuzumab deruxtecan can be safely used in liver failure and active leptomeningeal metastases. Curr Probl Cancer Case Rep. 2020 Dec 15; 2. PMID: [34505091](//www.ncbi.nlm.nih.gov/pubmed/34505091); PMCID: [PMC8425325](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8425325).

Citations:

  14. Bajgain P, Tawinwung S, D'Elia L, Sukumaran S, [Watanabe N](https://profiles.viictr.org/profile/3009961), **Hoyos V** , [Lulla P](https://profiles.viictr.org/profile/3010220), [Brenner MK](https://profiles.viictr.org/profile/268200), [Leen AM](https://profiles.viictr.org/profile/268626), Vera JF. CAR T cell therapy for breast cancer: harnessing the tumor milieu to drive T cell activation. J Immunother Cancer. 2018 05 10; 6(1):34. PMID: [29747685](//www.ncbi.nlm.nih.gov/pubmed/29747685); PMCID: [PMC5944113](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5944113).

Citations:
[39](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/29747685/citedby/) Fields:

Neo NeoplasmsThe Therapeutics

Translation:Humans

  15. **Hoyos V** , Borrello I. The immunotherapy era of myeloma: monoclonal antibodies, vaccines, and adoptive T-cell therapies. Blood. 2016 09 29; 128(13):1679-87. PMID: [27506540](//www.ncbi.nlm.nih.gov/pubmed/27506540).

Citations:
[24](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/27506540/citedby/) Fields:

Hem Hematology

Translation:HumansCells

  16. Yagyu S, **Hoyos V** , [Brenner MK](https://profiles.viictr.org/profile/268200), Del Bufalo F. Multiple mechanisms determine the sensitivity of human-induced pluripotent stem cells to the inducible caspase-9 safety switch. Mol Ther Methods Clin Dev. 2016; 3:16003. PMID: [27626039](//www.ncbi.nlm.nih.gov/pubmed/27626039); PMCID: [PMC5008202](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5008202).

Citations:
[8](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/27626039/citedby/)

  17. Manzo T, **Hoyos V** , Yagyu S, Jacot J, Benavides O, [Rosen D](https://profiles.viictr.org/profile/269898), [Brenner MK](https://profiles.viictr.org/profile/268200), Del Bufalo F, Caruana I. 3D modeling of human cancer: A PEG-fibrin hydrogel system to study the role of tumor microenvironment and recapitulate the in vivo effect of oncolytic adenovirus. Biomaterials. 2016 Apr; 84:76-85. PMID: [26826297](//www.ncbi.nlm.nih.gov/pubmed/26826297).

Citations:
[25](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/26826297/citedby/) Fields:

Bio Biomedical Engineering

Translation:HumansAnimalsCells

  18. **Hoyos V** , Del Bufalo F, Yagyu S, Ando M, Dotti G, [Suzuki M](https://profiles.viictr.org/profile/265870), [Bouchier-Hayes L](https://profiles.viictr.org/profile/268519), Alemany R, [Brenner MK](https://profiles.viictr.org/profile/268200). Mesenchymal Stromal Cells for Linked Delivery of Oncolytic and Apoptotic Adenoviruses to Non-small-cell Lung Cancers. Mol Ther. 2015 Sep; 23(9):1497-506. PMID: [26084970](//www.ncbi.nlm.nih.gov/pubmed/26084970); PMCID: [PMC4817892](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4817892).

Citations:
[14](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/26084970/citedby/) Fields:

Mol Molecular BiologyThe Therapeutics

Translation:HumansAnimalsCells

  19. Yagyu S, **Hoyos V** , Del Bufalo F, [Brenner MK](https://profiles.viictr.org/profile/268200). An Inducible Caspase-9 Suicide Gene to Improve the Safety of Therapy Using Human Induced Pluripotent Stem Cells. Mol Ther. 2015 Sep; 23(9):1475-85. PMID: [26022733](//www.ncbi.nlm.nih.gov/pubmed/26022733); PMCID: [PMC4817893](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4817893).

Citations:
[48](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/26022733/citedby/) Fields:

Mol Molecular BiologyThe Therapeutics

Translation:HumansAnimalsCells

  20. Caruana I, Savoldo B, **Hoyos V** , Weber G, [Liu H](https://profiles.viictr.org/profile/265543), Kim ES, [Ittmann MM](https://profiles.viictr.org/profile/269566), Marchetti D, Dotti G. Heparanase promotes tumor infiltration and antitumor activity of CAR-redirected T lymphocytes. Nat Med. 2015 May; 21(5):524-9. PMID: [25849134](//www.ncbi.nlm.nih.gov/pubmed/25849134); PMCID: [PMC4425589](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4425589).

Citations:
[251](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25849134/citedby/)
Fields:

Med Medicine (General)Mol Molecular Biology

Translation:HumansAnimalsCells

  21. Ando M, **Hoyos V** , Yagyu S, Tao W, [Ramos CA](https://profiles.viictr.org/profile/267038), Dotti G, [Brenner MK](https://profiles.viictr.org/profile/268200), [Bouchier-Hayes L](https://profiles.viictr.org/profile/268519). Bortezomib sensitizes non-small cell lung cancer to mesenchymal stromal cell-delivered inducible caspase-9-mediated cytotoxicity. Cancer Gene Ther. 2014 Nov; 21(11):472-482. PMID: [25323693](//www.ncbi.nlm.nih.gov/pubmed/25323693); PMCID: [PMC4245333](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4245333).

Citations:
[21](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25323693/citedby/) Fields:

Gen GeneticsNeo NeoplasmsThe Therapeutics

Translation:HumansAnimalsCells

  22. Nishio N, Diaconu I, [Liu H](https://profiles.viictr.org/profile/265543), Cerullo V, Caruana I, **Hoyos V** , [Bouchier-Hayes L](https://profiles.viictr.org/profile/268519), Savoldo B, Dotti G. Armed oncolytic virus enhances immune functions of chimeric antigen receptor-modified T cells in solid tumors. Cancer Res. 2014 Sep 15; 74(18):5195-205. PMID: [25060519](//www.ncbi.nlm.nih.gov/pubmed/25060519); PMCID: [PMC4167556](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4167556).

Citations:
[128](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25060519/citedby/)
Fields:

Neo Neoplasms

Translation:AnimalsCells

  23. Geldres C, Savoldo B, **Hoyos V** , Caruana I, Zhang M, Yvon E, Del Vecchio M, [Creighton CJ](https://profiles.viictr.org/profile/265729), [Ittmann M](https://profiles.viictr.org/profile/269566), Ferrone S, Dotti G. T lymphocytes redirected against the chondroitin sulfate proteoglycan-4 control the growth of multiple solid tumors both in vitro and in vivo. Clin Cancer Res. 2014 Feb 15; 20(4):962-71. PMID: [24334762](//www.ncbi.nlm.nih.gov/pubmed/24334762); PMCID: [PMC3944408](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3944408).

Citations:
[36](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24334762/citedby/) Fields:

Neo Neoplasms

Translation:HumansAnimalsCells

  24. **Hoyos V** , Savoldo B, Dotti G. Genetic modification of human T lymphocytes for the treatment of hematologic malignancies. Haematologica. 2012 Nov; 97(11):1622-31. PMID: [22929977](//www.ncbi.nlm.nih.gov/pubmed/22929977); PMCID: [PMC3487433](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3487433).

Citations:
[8](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22929977/citedby/) Fields:

Hem Hematology

Translation:HumansAnimalsCells

  25. Giordano Attianese GM, Marin V, **Hoyos V** , Savoldo B, Pizzitola I, Tettamanti S, Agostoni V, Parma M, Ponzoni M, Bertilaccio MT, Ghia P, Biondi A, Dotti G, Biagi E. In vitro and in vivo model of a novel immunotherapy approach for chronic lymphocytic leukemia by anti-CD23 chimeric antigen receptor. Blood. 2011 May 05; 117(18):4736-45. PMID: [21406718](//www.ncbi.nlm.nih.gov/pubmed/21406718); PMCID: [PMC3100686](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3100686).

Citations:
[36](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21406718/citedby/) Fields:

Hem Hematology

Translation:HumansAnimalsCells

  26. Quintarelli C, Dotti G, Hasan ST, De Angelis B, **Hoyos V** , Errichiello S, Mims M, Luciano L, Shafer J, [Leen AM](https://profiles.viictr.org/profile/268626), [Heslop HE](https://profiles.viictr.org/profile/269811), [Rooney CM](https://profiles.viictr.org/profile/268355), Pane F, [Brenner MK](https://profiles.viictr.org/profile/268200), Savoldo B. High-avidity cytotoxic T lymphocytes specific for a new PRAME-derived peptide can target leukemic and leukemic-precursor cells. Blood. 2011 Mar 24; 117(12):3353-62. PMID: [21278353](//www.ncbi.nlm.nih.gov/pubmed/21278353); PMCID: [PMC3069675](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3069675).

Citations:
[42](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21278353/citedby/) Fields:

Hem Hematology

Translation:HumansCells

  27. Yvon E, Del Vecchio M, Savoldo B, **Hoyos V** , Anichini A, Dotti G, [Brenner MK](https://profiles.viictr.org/profile/268200), Dutour A. Immunotherapy of metastatic melanoma using genetically engineered GD2-specific T cells. Clin Cancer Res. 2009 Sep 15; 15(18):5852-60. PMID: [19737958](//www.ncbi.nlm.nih.gov/pubmed/19737958); PMCID: [PMC2745508](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2745508).

Citations:
[65](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19737958/citedby/) Fields:

Neo Neoplasms

Translation:HumansAnimalsCells

  28. Vera JF, **Hoyos V** , Savoldo B, Quintarelli C, Giordano Attianese GM, [Leen AM](https://profiles.viictr.org/profile/268626), [Liu H](https://profiles.viictr.org/profile/265543), Foster AE, [Heslop HE](https://profiles.viictr.org/profile/269811), [Rooney CM](https://profiles.viictr.org/profile/268355), [Brenner MK](https://profiles.viictr.org/profile/268200), Dotti G. Genetic manipulation of tumor-specific cytotoxic T lymphocytes to restore responsiveness to IL-7. Mol Ther. 2009 May; 17(5):880-8. PMID: [19259067](//www.ncbi.nlm.nih.gov/pubmed/19259067); PMCID: [PMC2835146](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2835146).

Citations:
[56](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19259067/citedby/) Fields:

Mol Molecular BiologyThe Therapeutics

Translation:HumansAnimalsCells

  29. Quintarelli C, Dotti G, De Angelis B, **Hoyos V** , Mims M, Luciano L, [Heslop HE](https://profiles.viictr.org/profile/269811), [Rooney CM](https://profiles.viictr.org/profile/268355), Pane F, Savoldo B. Cytotoxic T lymphocytes directed to the preferentially expressed antigen of melanoma (PRAME) target chronic myeloid leukemia. Blood. 2008 Sep 01; 112(5):1876-85. PMID: [18591381](//www.ncbi.nlm.nih.gov/pubmed/18591381); PMCID: [PMC3401035](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3401035).

Citations:
[50](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/18591381/citedby/) Fields:

Hem Hematology

Translation:HumansCells

This graph shows the total number of publications by year. To see the data as
text, click here.

![Bar chart showing 29 publications over 14 distinct years, with a maximum of
6 publications in
2021](//chart.googleapis.com/chart?chs=595x100&chf=bg,s,ffffff|c,s,ffffff&chxt=x,y&chxl=0:|'94||'96||'98||'00||'02||'04||'06||'08||'10||'12||'14||'16||'18||'20||'22||'24|1:|0|6&cht=bvs&chd=t:0,0,0,0,0,0,0,0,0,0,0,0,0,0,17,33,0,33,17,17,33,50,50,0,17,0,17,100,33,17,50&chdl=Publications&chco=80B1D3&chbh=10)

This graph shows the total number of publications by year. To return to the
graph, click here.

Year| Publications  
---|---  
2008| 1  
2009| 2  
2011| 2  
2012| 1  
2013| 1  
2014| 2  
2015| 3  
2016| 3  
2018| 1  
2020| 1  
2021| 6  
2022| 2  
2023| 1  
2024| 3  
  
This graph shows the number and percent of publications by field. Fields are
based on how the National Library of Medicine (NLM) classifies the
publications' journals and might not represent the specific topics of the
publications. Note that an individual publication can be assigned to more than
one field. As a result, the publication counts in this graph might add up to
more than the number of publications the person has written. To see the data
as text, click here.

This graph shows the number and percent of publications by field. Fields are
based on how the National Library of Medicine (NLM) classifies the
publications' journals and might not represent the specific topics of the
publications. Note that an individual publication can be assigned to more than
one field. As a result, the publication counts in this graph might add up to
more than the number of publications the person has written. To see the data
as text, click here.

Start with: newest oldest Include: line numbers double spacing all authors
publication IDs

HOYOS's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (173)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

Derived automatically from this person's publications.

  * [Receptors, TNF-Related Apoptosis-Inducing Ligand](https://profiles.viictr.org/profile/261130)
  * [Myeloid-Derived Suppressor Cells](https://profiles.viictr.org/profile/27545207)
  * [Oncolytic Virotherapy](https://profiles.viictr.org/profile/243865)
  * [Receptors, Antigen, T-Cell](https://profiles.viictr.org/profile/244627)
  * [Adenoviridae](https://profiles.viictr.org/profile/253827)

[Explore](https://profiles.viictr.org/profile/23479202/198)

_

Co-Authors (32)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

People in Profiles who have published with this person.

  * [SHAFER, Paul](https://profiles.viictr.org/profile/24845191)
  * [LEEN, ANN](https://profiles.viictr.org/profile/268626)
  * [BRENNER, MALCOLM](https://profiles.viictr.org/profile/268200)
  * [RIMAWI, MOTHAFFAR](https://profiles.viictr.org/profile/269416)
  * [Somes, Lauren](https://profiles.viictr.org/profile/28999354)

[Explore](https://profiles.viictr.org/profile/23479202/345)

_

Similar People (60)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

People who share similar concepts with this person.

  * [GOTTSCHALK, STEPHEN](https://profiles.viictr.org/profile/270181)
  * [BRENNER, MALCOLM](https://profiles.viictr.org/profile/268200)
  * [HESLOP, HELEN](https://profiles.viictr.org/profile/269811)
  * [ROONEY, CLIONA](https://profiles.viictr.org/profile/268355)
  * [KANTARJIAN, HAGOP M](https://profiles.viictr.org/profile/12582901)

[Explore](https://profiles.viictr.org/profile/23479202/476)

_

Same Department [ ![Expand
Description](https://profiles.viictr.org/Framework/Images/info.png)
](JavaScript:toggleVisibility\('sdDescript'\);)

People who are also in this person's primary department.

  * [ABUASAB, TAREQ](https://profiles.viictr.org/profile/41013844)
  * [ECKHARDT, GAIL](https://profiles.viictr.org/profile/41109789)
  * [FUQUA, SUZANNE](https://profiles.viictr.org/profile/269832)
  * [JOTWANI, APARNA](https://profiles.viictr.org/profile/23478807)
  * [LI, ANG](https://profiles.viictr.org/profile/29964662)

[Explore](https://profiles.viictr.org/search/default.aspx?searchtype=people&searchfor=&SearchRequest=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)

_

